Kidney Allograft Monitoring by Combining Donor-Derived Cell-Free DNA and Molecular Gene Expression: A Clinical Management Perspective

Kidney Allograft Monitoring by Combining Donor-Derived Cell-Free DNA and Molecular Gene Expression: A Clinical Management Perspective

Donor-derived cell-free DNA (dd-cfDNA) may safely assess kidney allograft rejection. Molecular Microscope (MMDx<sup>®</sup>) gene expression may offer increased precision to histology. This single-center retrospective study monitored kidney transplant recipients for rejection at specifie...

Full description

Bibliographic Details
Main Authors:	Asim Rizvi, Sara Faiz, Parin H. Thakkar, Syed Hussain, Ann N. Gamilla-Crudo, Michael Kueht, Muhammad A. Mujtaba
Format:	Article
Language:	English
Published:	MDPI AG 2023-07-01
Series:	Journal of Personalized Medicine
Subjects:	donor-derived cell-free DNA Molecular Microscope Diagnostic System (MMDx<sup>®</sup>) rejection antibody-mediated rejection donor-specific antibody
Online Access:	https://www.mdpi.com/2075-4426/13/8/1205

Similar Items

Efficacy and safety of bortezomib in the treatment of active antibody-mediated rejection in adult kidney-transplant recipients: A single-center retrospective study
by: Dharmendra Bhadauria, et al.
Published: (2022-01-01)

The relevance of complement C4d staining in renal allograft biopsies
by: Anju Khairwa
Published: (2020-01-01)

Clinical significance of donor-specific anti-HLA-DR51/52/53 antibodies for antibody-mediated rejection in kidney transplant recipients
by: Borae Geum Park, et al.
Published: (2019-09-01)

Spot Urine Protein Excretion in the First Year Following Kidney Transplantation Associates With Allograft Rejection Phenotype at 1-Year Surveillance Biopsies: An Observational National-Cohort Study
by: Manca Oblak, et al.
Published: (2021-11-01)

Rigetto anticorpo-mediato nel trapianto di rene: fisiopatologia, clinica e terapia
by: Aris Tsalouchos, et al.
Published: (2020-10-01)

A pathogenesis-based transcript signature in donor-specific antibody-positive kidney transplant patients with normal biopsies
by: P. Ó Broin, et al.
Published: (2014-12-01)

Mouse Model Established by Early Renal Transplantation After Skin Allograft Sensitization Mimics Clinical Antibody-Mediated Rejection
by: Daqiang Zhao, et al.
Published: (2018-07-01)

Vascular rejection in cardiac allograft vasculopathy: Impact on graft survival
by: Nandini Nair
Published: (2022-08-01)

Characteristics of Donor-Specific Antibodies Associated With Antibody-Mediated Rejection in Lung Transplantation
by: Antoine Roux, et al.
Published: (2017-10-01)

Management of donor-specific antibodies in lung transplantation
by: William Brandon, et al.
Published: (2023-09-01)

Treatment of donor‐specific antibody‐mediated rejection after heart transplantation by IgM‐enriched human immunoglobulin
by: Moritz Benjamin Immohr, et al.
Published: (2021-08-01)

A modified perioperative regimen for deceased donor kidney transplantation in presensitized recipients without prior desensitization therapy
by: Zhiliang Guo, et al.
Published: (2023-07-01)

Safety, tolerability, and efficacy of monoclonal CD38 antibody felzartamab in late antibody-mediated renal allograft rejection: study protocol for a phase 2 trial
by: Katharina A. Mayer, et al.
Published: (2022-04-01)

Editorial: Sensitization and Desensitization in Organ Transplantation
by: Imran J. Anwar, et al.
Published: (2021-10-01)

De Novo Donor-Specific Antibodies after Heart Transplantation: A Comprehensive Guide for Clinicians
by: Irene Marco, et al.
Published: (2023-12-01)

CD4+ T Cell Help Is Mandatory for Naive and Memory Donor-Specific Antibody Responses: Impact of Therapeutic Immunosuppression
by: Chien-Chia Chen, et al.
Published: (2018-02-01)

Antibody-dependent NK cell activation is associated with late kidney allograft dysfunction and the complement-independent alloreactive potential of donor-specific antibodies
by: Tristan Legris, et al.
Published: (2016-08-01)

Allo-Specific Humoral Responses: New Methods for Screening Donor-Specific Antibody and Characterization of HLA-Specific Memory B Cells
by: Shengli Song, et al.
Published: (2021-07-01)

IL-21 Receptor Blockade Shifts the Follicular T Cell Balance and Reduces De Novo Donor-Specific Antibody Generation
by: Yeqi Nian, et al.
Published: (2021-04-01)

The Current State of Donor-Derived Cell-Free DNA Use in Allograft Monitoring in Kidney Transplantation
by: Michael L. Kueht, et al.
Published: (2022-10-01)

Treatment of Antibody-Mediated Rejection in Kidney Transplantation
by: Magdalena Durlik
Published: (2013-07-01)

The natural history of de novo donor-specific HLA antibodies after kidney transplantation
by: Covadonga López del Moral, et al.
Published: (2022-09-01)

Case report: Daratumumab for treatment of refractory late or chronic active antibody-mediated rejection in renal allograft recipients with high levels of de novo donor-specific antibodies
by: Lan Zhu, et al.
Published: (2023-01-01)

Antibody-mediated rejection in heart transplantation
by: V. S. Kvan, et al.
Published: (2022-01-01)

The Role of the Endothelium during Antibody-Mediated Rejection: From Victim to Accomplice
by: Amy Rachael Cross, et al.
Published: (2018-01-01)

Methods to Detect MHC-Specific IgE in Mice and Men
by: Anna Marianne Weijler, et al.
Published: (2020-12-01)

Pre-transplant HLA Antibodies and Delayed Graft Function in the Current Era of Kidney Transplantation
by: Christian Morath, et al.
Published: (2020-08-01)

Impact of Preformed Donor-Specific Anti-HLA-Cw and Anti-HLA-DP Antibodies on Acute Antibody-Mediated Rejection in Kidney Transplantation
by: Timothée Laboux, et al.
Published: (2023-11-01)

Early Posttransplant Blood Transfusion and Risk for Worse Graft Outcomes
by: Reem Daloul, et al.
Published: (2021-04-01)

Immunosuppression Has Long-Lasting Effects on Circulating Follicular Regulatory T Cells in Kidney Transplant Recipients
by: Qian Niu, et al.
Published: (2020-08-01)

Diagnostic Performance of Donor-Derived Plasma Cell-Free DNA Fraction for Antibody-Mediated Rejection in Post Renal Transplant Recipients: A Prospective Observational Study
by: Huanxi Zhang, et al.
Published: (2020-02-01)

Clinical Case: Patient with Mixed Graft Rejection Four Days after Kidney Transplantation Developed Specific Antibodies against Donor Bw4 Specificities
by: Claudia M. Muñoz-Herrera, et al.
Published: (2021-07-01)

Time-dependent blood eosinophilia count increases the risk of kidney allograft rejection
by: Luc Colas, MD, PhD, et al.
Published: (2021-11-01)

Clazakizumab in late antibody-mediated rejection: study protocol of a randomized controlled pilot trial
by: Farsad Eskandary, et al.
Published: (2019-01-01)

Misidentification of preformed anti-HLA-DP antibodies leads to antibody-mediated kidney transplant rejection: a case report
by: Duangtawan Thammanichanond, et al.
Published: (2022-05-01)

New insights into maladaptive vascular responses to donor specific HLA antibodies in organ transplantation
by: Adriana Franco-Acevedo, et al.
Published: (2023-04-01)

Tocilizumab and Active Antibody-Mediated Rejection in Kidney Transplantation: A Literature Review
by: Lara Cabezas, et al.
Published: (2022-04-01)

Renal allograft rejection, lymphocyte infiltration, and de novo donor-specific antibodies in a novel model of non-adherence to immunosuppressive therapy
by: Louisa Kühne, et al.
Published: (2017-12-01)

Circulating donor-derived cell-free DNA as a marker for rejection after lung transplantation
by: Yunhui Li, et al.
Published: (2023-10-01)

ECDI‐fixed donor splenocytes prolong skin allograft survival by promoting M2 macrophage polarization and inducing regulatory T cells
by: Bo Zhou, et al.
Published: (2019-11-01)